| Gene symbol | CDA | Synonyms | CDD | Type of gene | protein-coding |
| Chromosome | 1 | Map location | 1p36.12 | dbXrefs | |
| Description | cytidine deaminase | ||||
| GTO ID | GTC1564 |
| Trial ID | NCT02598011 |
| Disease | High Grade Glioma |
| Altered gene | CDA |
| Therapeutic/Target gene | Therapeutic gene |
| Therapy | Gene transfer |
| Treatment | Toca 511|vocimagene amiretrorepvec |
| Co-treatment | Flucytosine |
| Phase | Phase1 |
| Recruitment status | Withdrawn |
| Title | The Toca 7 Study: A Phase 1b Study of the Safety of Toca 511, a Retroviral Replicating Vector, Combined With Toca FC in Subjects With Newly Diagnosed High Grade Glioma Receiving Standard of Care |
| Year | 2015 |
| Country | United States |
| Company sponsor | Tocagen Inc. |
| Other ID(s) | Tg 511-15-03 |
| Vector information | |||||
|
|||||
| Cohort 1 | |||||||||
|
|||||||||